It concerned the Department’s interpretation of the Dispute Resolution Panel’s decision of 27 May 2011, in the case of the Department of Health and GlaxoSmithKline UK Limited.
See Pharmaceutical Price Regulation Scheme Dispute Resolution Panel decisions.
The decision has also been published on the Association of the British Pharmaceutical Industry website.